A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine.
Masayuki Umeda, Tadakazu Kondo, Momoko Nishikori, Toshiyuki Kitano, Masakatsu Hishizawa, Norimitsu Kadowaki, Akifumi Takaori-Kondo
Author Information
Masayuki Umeda: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Tadakazu Kondo: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Momoko Nishikori: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Toshiyuki Kitano: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Masakatsu Hishizawa: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Norimitsu Kadowaki: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Akifumi Takaori-Kondo: Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan.
Currently, there is no standard treatment for neurolymphomatosis because of the scarcity of clinical studies. Here, we report the successful treatment of neurolymphomatosis caused by follicular lymphoma with bendamustine, which could be an effective treatment option for this condition.
J Cancer Res Clin Oncol. 2002 Feb;128(2):111-3
[PMID: 11862482 ]
Blood. 2010 Jun 17;115(24):5005-11
[PMID: 20368468 ]
J Neurooncol. 2014 May;118(1):155-62
[PMID: 24584709 ]
J Clin Oncol. 2005 May 20;23(15):3383-9
[PMID: 15908650 ]
Brain. 2013 Aug;136(Pt 8):2563-78
[PMID: 23884813 ]
Clin Case Rep. 2015 Nov 09;4(1):23-5
[PMID: 26783429 ]
J Neurooncol. 2012 May;107(3):659-63
[PMID: 22249693 ]
